Homocysteine and other thiol compounds in ageing

BioFactors

Volumn 11, Issue 1-2, 2000, Pages 47-49

  Hernanz, A ^a   Fernandez Vivancos E ^a   Salazar, R M ^a   Arnalich, F ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; GLUTATHIONE; HOMOCYSTEINE; THIOL DERIVATIVE;

ADULT; AGED; AGING; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; HUMAN; MALE;

ADULT; AGED; AGED, 80 AND OVER; AGING; CYSTEINE; FEMALE; GLUTATHIONE; HOMOCYSTEINE; HUMANS; MALE; SULFHYDRYL COMPOUNDS;

EID: 0033632159     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520110113     Document Type: Article

References (11)

1. I. Brattström, A. Lindgren, B. Israelsson, M.R. Malinow, B. Norrving, B. Upson and A. Hamfelt, Hyperhomocysteinemia in stroke: Prevalence, cause, and relationships to type of stroke and stroke risk factors, Eur. J. Clin. Invest. 22 (1982), 214-221.
2. B.M. Coull, M.R. Malinow, N. Beamer, G. Sexton, F. Nordt and P. de Garmo, Elevated plasma homocysteine concentration as a possible independent risk factor for stroke, Stroke 21 (1990), 572-576.
3. M. Den Heijer, T. Koster T.H.J. Blom, G.M.J. Bos, E. Briët, P.H. Reitsma, J.P. Vandenbrougke and F.R. Rosendaal, Hyperhomocysteinemia as a risk factor for deep-vein thrombosis, New Engl. J. Med. 334 (1996), 759-762.
4. P.C. Harpe, V.T. Chang and W. Borth, Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: A potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism, Proc. Natl. Acad. Sci. 89 (1992), 10 193-10 197.
5. E.K. Hoogeveen, P.J. Kostense, P.J. Becks, A.J.C. Mackaay, C. Jakobs, L.M. Bouter, R.J. Heine and C.D.A. Stehouwer, Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus. A population-based study, Arterioscler. Thromb. Vasc. Biol. 18 (1998), 133-138.
6. S.M. Lynch and B. Frei, Physiological thiol compounds exert pro-and anti-oxidant effects, respectively, on iron-and copper-dependent oxidation of human low-density lipoprotein, Biochim. Biophys. Acta 1345 (1997), 215-221.
7. F. Michelet, R. Guegen, P. Leroy, M. Wellman, A. Nicolasand and G. Siest, Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits, Clin. Chem. 41 (1995), 1509-1517.
8. O. Nygard, S.E. Vollset, H. Refsum, I. Stensvold, A. Tverdal, I.E. Nordrehaug, P.M. Ueland and G. Kvale, Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study, JAMA 274 (1995), 1526-1533.
9. J.B. Ubbink, W.J.H. Vermaak and S. Bissbort, Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum, J. Chromat. 565 (1991), 441-446.
10. J.B. Ubbink, W.J.H. Vermaak, A. van der Merwe and P.J. Becker, Vitamin B-12, vitamin B-6 and folate nutritional status in men with hyperhomocysteinemia, Am. J. Clin. Nutr. 57 (1993), 47-53.
11. P.M. Ueland, M.A. Mansoor, A.B. Guttormsen, F. Muller, P. Aukrust, H. Refsum and A.M. Svardal, Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status - a possible element of the extracellular antioxidant defense syste, J. Nutr. 126 (1996), 1281S-1284S.